Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Moudgil

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Circulation|April 16, 2003
In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic ratsZlatko I Pozeg, Evangelos D Michelakis, M Sean McMurtry, et al.
Circulation|July 4, 2007
Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractilityJayan Nagendran, Stephen L Archer, Daniel Soliman, et al.
Plos One|March 22, 2014
A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD studyBenjamin Hibbert, Ronnen Maze, Ali Pourdjabbar, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 6, 2024
Surgical resection of benign primary cardiac tumors: A 6-decade evaluation of survival and recurrenceAnnalisa Bernabei, Andrew J Toth, A Marc Gillinov, et al.
Plos Medicine|August 2, 2021
Cardiac risk stratification in cancer patients: A longitudinal patient-patient network analysisYuan Hou, Yadi Zhou, Muzna Hussain, et al.
Open Heart|November 27, 2020
Impact of timing of atrial fibrillation, CHA<sub>2</sub>DS<sub>2</sub>-VASc score and cancer therapeutics on mortality in oncology patientsMuzna Hussain, Rabel Misbah, Eoin Donnellan, et al.
Journal of the American Heart Association|November 26, 2020
Machine Learning-Based Risk Assessment for Cancer Therapy-Related Cardiac Dysfunction in 4300 Longitudinal Oncology PatientsYadi Zhou, Yuan Hou, Muzna Hussain, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
EPR25-121: Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Cancer Patients: Testing and Referral GuidelinesTeodora Kuzmanovic, Maedeh Zoakei Nikoo, Sindhusha Veereballi, et al.
Heart Failure Reviews|March 20, 2026
Diagnostics in cardio-oncology: a focus on anthracyclinesAshot Avagimyan, Nana Pogosova, Daniela Cardinale, et al.
The American Journal of Cardiology|September 29, 2020
Temporal Trends of Cardiac Outcomes and Impact on Survival in Patients With CancerMuzna Hussain, Yuan Hou, Chris Watson, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Circulation|April 16, 2003
In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic ratsZlatko I Pozeg, Evangelos D Michelakis, M Sean McMurtry, et al.
Circulation|July 4, 2007
Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractilityJayan Nagendran, Stephen L Archer, Daniel Soliman, et al.
Plos One|March 22, 2014
A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD studyBenjamin Hibbert, Ronnen Maze, Ali Pourdjabbar, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 6, 2024
Surgical resection of benign primary cardiac tumors: A 6-decade evaluation of survival and recurrenceAnnalisa Bernabei, Andrew J Toth, A Marc Gillinov, et al.
Plos Medicine|August 2, 2021
Cardiac risk stratification in cancer patients: A longitudinal patient-patient network analysisYuan Hou, Yadi Zhou, Muzna Hussain, et al.
Open Heart|November 27, 2020
Impact of timing of atrial fibrillation, CHA<sub>2</sub>DS<sub>2</sub>-VASc score and cancer therapeutics on mortality in oncology patientsMuzna Hussain, Rabel Misbah, Eoin Donnellan, et al.
Journal of the American Heart Association|November 26, 2020
Machine Learning-Based Risk Assessment for Cancer Therapy-Related Cardiac Dysfunction in 4300 Longitudinal Oncology PatientsYadi Zhou, Yuan Hou, Muzna Hussain, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
EPR25-121: Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Cancer Patients: Testing and Referral GuidelinesTeodora Kuzmanovic, Maedeh Zoakei Nikoo, Sindhusha Veereballi, et al.
Heart Failure Reviews|March 20, 2026
Diagnostics in cardio-oncology: a focus on anthracyclinesAshot Avagimyan, Nana Pogosova, Daniela Cardinale, et al.
The American Journal of Cardiology|September 29, 2020
Temporal Trends of Cardiac Outcomes and Impact on Survival in Patients With CancerMuzna Hussain, Yuan Hou, Chris Watson, et al.
Pageof 8